Literature DB >> 3348668

Neonatal screening for cystic fibrosis.

F Bowling1, G Cleghorn, A Chester, J Curran, B Griffin, J Prado, P Francis, R Shepherd.   

Abstract

Two groups of patients with cystic fibrosis were compared. The screened group, detected with an improved neonatal screening assay for immunoreactive trypsin, developed fewer chest infections requiring treatment and gained more weight than the unscreened group. Early diagnosis by screening seems to affect early morbidity.

Entities:  

Mesh：

Year:  1988        PMID： 3348668      PMCID： PMC1778742          DOI： 10.1136/adc.63.2.196

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  4 in total

1.  Reduced morbidity in patients with cystic fibrosis detected by neonatal screening.

Authors:  B Wilcken; G Chalmers
Journal:  Lancet       Date:  1985-12-14       Impact factor: 79.321

2.  Neonatal screening for cystic fibrosis, using immunoreactive trypsin assay in dried blood spots.

Authors:  J R Crossley; P A Smith; B W Edgar; P D Gluckman; R B Elliott
Journal:  Clin Chim Acta       Date:  1981-06-18       Impact factor: 3.786

3.  Cystic fibrosis screening by dried blood spot trypsin assay: results in 75,000 newborn infants.

Authors:  B Wilcken; A R Brown; R Urwin; D A Brown
Journal:  J Pediatr       Date:  1983-03       Impact factor: 4.406

4.  Monoclonal antibody-based enzyme immunoassay for trypsinogen in neonatal screening for cystic fibrosis.

Authors:  F G Bowling; A R Watson; D B Rylatt; J E Elliott; R J Bunch; P G Bundesen
Journal:  Lancet       Date:  1987-04-11       Impact factor: 79.321
  4 in total
  6 in total

Review 1.  Neonatal screening--should we or shouldn't we?

Authors:  P H Weller; J V West
Journal:  J R Soc Med       Date:  1991       Impact factor: 5.344

Review 2.  Periodic health examination, 1991 update: 4. Screening for cystic fibrosis. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1991-09-15       Impact factor: 8.262

3.  Neonatal screening part 3: controversial issues.

Authors:  B A Morris
Journal:  Can Fam Physician       Date:  1990-03       Impact factor: 3.275

4.  Is community screening for amblyopia possible, or appropriate?

Authors:  M C Wright; D J Colville; F Oberklaid
Journal:  Arch Dis Child       Date:  1995-09       Impact factor: 3.791

5.  Cystic fibrosis screening in neonates--measurement of immunoreactive trypsin and direct genotype analysis for delta F508 mutation.

Authors:  J Larsen; S Campbell; E B Faragher; M Götz; I Eichler; S Waldherr; K Dobianer; J Spona
Journal:  Eur J Pediatr       Date:  1994-08       Impact factor: 3.183

6.  Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after five years of screening.

Authors:  S Chatfield; G Owen; H C Ryley; J Williams; M Alfaham; M C Goodchild; P Weller
Journal:  Arch Dis Child       Date:  1991-01       Impact factor: 3.791
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.